EC: 5.3.99.3
prostaglandin-E synthase ((5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate E-isomerase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:META_PWY66-374 | C20 prostanoid biosynthesis |
| BioCyc:HUMAN_PWY66-374 | C20 prostanoid biosynthesis |
| BioCyc:MOUSE_PWY3DJ-35583 | biosynthesis of prostaglandins |
| Reactome:R-HSA-9679506 | SARS-CoV Infections |
| Reactome:R-HSA-9679191 | Potential therapeutics for SARS |
| Reactome:R-HSA-9824446 | Viral Infection Pathways |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-BTA-556833 | Metabolism of lipids |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-CFA-556833 | Metabolism of lipids |
| Reactome:R-DME-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-DME-9018519 | Estrogen-dependent gene expression |
| Reactome:R-DME-3371511 | HSF1 activation |
| Reactome:R-DME-8937144 | Aryl hydrocarbon receptor signalling |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-3371571 | HSF1-dependent transactivation |
| Reactome:R-HSA-1643685 | Disease |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-556833 | Metabolism of lipids |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-MMU-3371568 | Attenuation phase |
| Reactome:R-MMU-3371497 | HSP90 chaperone cycle for SHRs |
| Reactome:R-MMU-162582 | Signaling Pathways |
| Reactome:R-MMU-8939211 | ESR-mediated signaling |
| Reactome:R-RNO-8978868 | Fatty acid metabolism |
| Reactome:R-RNO-2162123 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |
| Reactome:R-RNO-211945 | Phase I - Functionalization of compounds |
| Reactome:R-RNO-3371571 | HSF1-dependent transactivation |
| Reactome:R-RNO-162582 | Signaling Pathways |
| Reactome:R-RNO-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-RNO-9018519 | Estrogen-dependent gene expression |
| Reactome:R-BTA-8978868 | Fatty acid metabolism |
| Reactome:R-BTA-2162123 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |
| Reactome:R-CFA-8978868 | Fatty acid metabolism |
| Reactome:R-CFA-2162123 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |
| Reactome:R-DME-162582 | Signaling Pathways |
| Reactome:R-DME-8939211 | ESR-mediated signaling |
| Reactome:R-DME-8953897 | Cellular responses to stimuli |
| Reactome:R-DME-3371556 | Cellular response to heat stress |
| Reactome:R-DME-1430728 | Metabolism |
| Reactome:R-DME-211945 | Phase I - Functionalization of compounds |
| Reactome:R-HSA-556833 | Metabolism of lipids |
| Reactome:R-HSA-8978868 | Fatty acid metabolism |
| Reactome:R-HSA-2162123 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |
| Reactome:R-HSA-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-HSA-9018519 | Estrogen-dependent gene expression |
| Reactome:R-HSA-2262752 | Cellular responses to stress |
| Reactome:R-HSA-3371511 | HSF1 activation |
| Reactome:R-MMU-8978868 | Fatty acid metabolism |
| Reactome:R-MMU-2162123 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |
| Reactome:R-MMU-3371571 | HSF1-dependent transactivation |
| Reactome:R-RNO-2142753 | Arachidonate metabolism |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-RNO-8953897 | Cellular responses to stimuli |
| Reactome:R-RNO-2262752 | Cellular responses to stress |
| Reactome:R-RNO-3371511 | HSF1 activation |
| Reactome:R-RNO-8939211 | ESR-mediated signaling |
| Reactome:R-DME-2262752 | Cellular responses to stress |
| Reactome:R-DME-3371571 | HSF1-dependent transactivation |
| Reactome:R-DME-3371497 | HSP90 chaperone cycle for SHRs |
| Reactome:R-HSA-211945 | Phase I - Functionalization of compounds |
| Reactome:R-HSA-3371568 | Attenuation phase |
| Reactome:R-HSA-3371497 | HSP90 chaperone cycle for SHRs |
| Reactome:R-MMU-211945 | Phase I - Functionalization of compounds |
| Reactome:R-MMU-3371556 | Cellular response to heat stress |
| Reactome:R-MMU-9006931 | Signaling by Nuclear Receptors |
| Reactome:R-MMU-9018519 | Estrogen-dependent gene expression |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-556833 | Metabolism of lipids |
| Reactome:R-RNO-8937144 | Aryl hydrocarbon receptor signalling |
| Reactome:R-RNO-3371568 | Attenuation phase |
| Reactome:R-RNO-3371497 | HSP90 chaperone cycle for SHRs |
| Reactome:R-BTA-2142753 | Arachidonate metabolism |
| Reactome:R-CFA-2142753 | Arachidonate metabolism |
| Reactome:R-DME-3371568 | Attenuation phase |
| Reactome:R-DME-211859 | Biological oxidations |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-2142753 | Arachidonate metabolism |
| Reactome:R-HSA-8937144 | Aryl hydrocarbon receptor signalling |
| Reactome:R-HSA-162582 | Signaling Pathways |
| Reactome:R-HSA-8939211 | ESR-mediated signaling |
| Reactome:R-HSA-8953897 | Cellular responses to stimuli |
| Reactome:R-HSA-3371556 | Cellular response to heat stress |
| Reactome:R-HSA-5663205 | Infectious disease |
| Reactome:R-MMU-2142753 | Arachidonate metabolism |
| Reactome:R-MMU-8937144 | Aryl hydrocarbon receptor signalling |
| Reactome:R-MMU-8953897 | Cellular responses to stimuli |
| Reactome:R-MMU-2262752 | Cellular responses to stress |
| Reactome:R-MMU-3371511 | HSF1 activation |
| Reactome:R-RNO-3371556 | Cellular response to heat stress |
| WikiPathways:WP5088 | Prostaglandin signaling |
| PathBank:SMP0000083 | Acetylsalicylic Acid Action Pathway |
| PathBank:SMP0000087 | Rofecoxib Action Pathway |
| PathBank:SMP0000094 | Sulindac Action Pathway |
| PathBank:SMP0000104 | Indomethacin Action Pathway |
| PathBank:SMP0000120 | Naproxen Action Pathway |
| PathBank:SMP0000106 | Meloxicam Action Pathway |
| PathBank:SMP0000693 | Antrafenine Action Pathway |
| PathBank:SMP0000697 | Flurbiprofen Action Pathway |
| PathBank:SMP0000701 | Phenylbutazone Action Pathway |
| PathBank:SMP0000705 | Tiaprofenic Acid Action Pathway |
| PathBank:SMP0000709 | Salicylic Acid Action Pathway |
| PathBank:SMP0000075 | Arachidonic Acid Metabolism |
| PathBank:SMP0000086 | Ibuprofen Action Pathway |
| PathBank:SMP0000093 | Diclofenac Action Pathway |
| PathBank:SMP0000098 | Ketorolac Action Pathway |
| PathBank:SMP0000102 | Bromfenac Action Pathway |
| PathBank:SMP0000114 | Nabumetone Action Pathway |
| PathBank:SMP0000692 | Antipyrine Action Pathway |
| PathBank:SMP0000696 | Fenoprofen Action Pathway |
| PathBank:SMP0000700 | Lornoxicam Action Pathway |
| PathBank:SMP0000704 | Tolmetin Action Pathway |
| PathBank:SMP0000708 | Salicylate-Sodium Action Pathway |
| PathBank:SMP0063595 | Arachidonic Acid Metabolism |
| PathBank:SMP0000077 | Piroxicam Action Pathway |
| PathBank:SMP0000084 | Etodolac Action Pathway |
| PathBank:SMP0000109 | Mefenamic Acid Action Pathway |
| PathBank:SMP0000289 | Diflunisal Action Pathway |
| PathBank:SMP0000116 | Valdecoxib Action Pathway |
| PathBank:SMP0000694 | Carprofen Action Pathway |
| PathBank:SMP0000698 | Magnesium Salicylate Action Pathway |
| PathBank:SMP0000702 | Nepafenac Action Pathway |
| PathBank:SMP0000706 | Tenoxicam Action Pathway |
| PathBank:SMP0000710 | Acetaminophen Action Pathway |
| PathBank:SMP0120510 | Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000353 | Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000085 | Ketoprofen Action Pathway |
| PathBank:SMP0000096 | Celecoxib Action Pathway |
| PathBank:SMP0000101 | Suprofen Action Pathway |
| PathBank:SMP0000113 | Oxaprozin Action Pathway |
| PathBank:SMP0000695 | Etoricoxib Action Pathway |
| PathBank:SMP0000699 | Lumiracoxib Action Pathway |
| PathBank:SMP0000703 | Trisalicylate-Choline Action Pathway |
| PathBank:SMP0000707 | Salsalate Action Pathway |